Research Progress of Spironolactone as an Antagonist of NRG1-ERBB4 Pathway in the Treatment of Cognitive Impairment in Schizophrenia
Rhabdomyolysis and Staphylococcus Aureus Sepsis Secondary to Influenza A Infection: A Case Report and Review of the Literature